
Crown Aesthetics said its SkinPen device has received three new approved indications, expanding its use cases as a medical microneedling treatment. The certification confirms SkinPen Precision as a treatment which can help to improve the appearance of surgical scars, stretch marks, and enlarged pores on all areas of the body.
The device is also approved for medical purposes to treat facial acne scars in adults aged 22 years or older and for aesthetic purposes to help improve the cosmetic appearance of fine lines, wrinkles, and pigmentation conditions (dyschromia).
"As a brand, we are continually raising the bar in the microneedling market," said Andy Moulton, Vice President, Sales, International for Crown Aesthetics. "This new certification not only solidifies our status as the leading, most advanced skin remodeling treatment system, but it also enables us to further our global consumer reach. We are committed to supporting our customers' skin health journey by helping them visibly transform and improve the appearance of their skin without surgical intervention."